Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10590411rdf:typepubmed:Citationlld:pubmed
pubmed-article:10590411lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10590411lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:10590411lifeskim:mentionsumls-concept:C0006556lld:lifeskim
pubmed-article:10590411lifeskim:mentionsumls-concept:C0231220lld:lifeskim
pubmed-article:10590411lifeskim:mentionsumls-concept:C0011155lld:lifeskim
pubmed-article:10590411lifeskim:mentionsumls-concept:C1420102lld:lifeskim
pubmed-article:10590411lifeskim:mentionsumls-concept:C1159626lld:lifeskim
pubmed-article:10590411pubmed:issue1lld:pubmed
pubmed-article:10590411pubmed:dateCreated2000-1-20lld:pubmed
pubmed-article:10590411pubmed:abstractTextWe identified 5 patients with subnormal erythrocyte lactate transport plus symptoms and signs of muscle injury on exercise and heat exposure. All had transport rates below the 95% envelope for normals. Three cases had rates 40-50% of mean normal. One was found to have a missense mutation in monocarboxylate transporter 1 (MCT1), the gene for the red cell lactate transporter (also expressed in skeletal muscle), at a conserved site, which was not mutated in a cohort of 90 normal humans. The other 2 cases had a different missense mutation (at a nonconserved site), which was also not mutated in the normal cohort. All 3 patients were heterozygotes. We presume that these mutations are responsible for their subnormal lactate transport, and hence their muscle injury under environmental stress; homozygous patients should be more seriously compromised. The other 2 cases had lactate transport rates 60-65% of mean normal, and their MCT1 revealed a third mutation, which proved to be a common polymorphism in the normal cohort. These 2 patients may be physiologic outliers in lactate transport, with their muscle damage arising from some other genetic defect.lld:pubmed
pubmed-article:10590411pubmed:languageenglld:pubmed
pubmed-article:10590411pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10590411pubmed:citationSubsetIMlld:pubmed
pubmed-article:10590411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10590411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10590411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10590411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10590411pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10590411pubmed:statusMEDLINElld:pubmed
pubmed-article:10590411pubmed:monthJanlld:pubmed
pubmed-article:10590411pubmed:issn0148-639Xlld:pubmed
pubmed-article:10590411pubmed:authorpubmed-author:FishbeinW NWNlld:pubmed
pubmed-article:10590411pubmed:authorpubmed-author:DavisJ IJIlld:pubmed
pubmed-article:10590411pubmed:authorpubmed-author:FoellmerJ WJWlld:pubmed
pubmed-article:10590411pubmed:authorpubmed-author:Merezhinskaya...lld:pubmed
pubmed-article:10590411pubmed:copyrightInfoCopyright 2000 John Wiley & Sons, Inc.lld:pubmed
pubmed-article:10590411pubmed:issnTypePrintlld:pubmed
pubmed-article:10590411pubmed:volume23lld:pubmed
pubmed-article:10590411pubmed:ownerNLMlld:pubmed
pubmed-article:10590411pubmed:authorsCompleteYlld:pubmed
pubmed-article:10590411pubmed:pagination90-7lld:pubmed
pubmed-article:10590411pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:meshHeadingpubmed-meshheading:10590411...lld:pubmed
pubmed-article:10590411pubmed:year2000lld:pubmed
pubmed-article:10590411pubmed:articleTitleMutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport.lld:pubmed
pubmed-article:10590411pubmed:affiliationBiochemical Pathology Division, Environmental Pathology Department, Room M093C, Armed Forces Institute of Pathology, Washington, DC 20306-6000, USA.lld:pubmed
pubmed-article:10590411pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10590411pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10590411pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
literatureCitation:738_1059...literatureCitation:pubmedpubmed-article:10590411lld:drugbank
entrez-gene:6566entrezgene:pubmedpubmed-article:10590411lld:entrezgene